アルキル化の

関: alkylate、alkylation

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/07/03 10:00:48」(JST)

wiki en

Alkylation is the transfer of an alkyl group from one molecule to another. The alkyl group may be transferred as an alkyl carbocation, a free radical, a carbanion or a carbene (or their equivalents).^[1] Alkylating agents are widely used in chemistry because the alkyl group is probably the most common group encountered in organic molecules.^{[citation needed]} Many biological target molecules or their synthetic precursors are composed of an alkyl chain with specific functional groups in a specific order. Selective alkylation, or adding parts to the chain with the desired functional groups, is used, especially if there is no commonly available biological precursor. Alkylation with only one carbon is termed methylation.

In oil refining contexts, alkylation refers to a particular alkylation of isobutane with olefins. For upgrading of petroleum, alkylation produces synthetic C₇–C₈ alkylate, which is a premium blending stock for gasoline.^[2]

In medicine, alkylation of DNA is used in chemotherapy to damage the DNA of cancer cells. Alkylation is accomplished with the class of drugs called alkylating antineoplastic agents.

Benzene Friedel-Crafts alkylation.

Alkylating agents

"Alkylating agent" redirects here. For the class of drugs, see alkylating antineoplastic agent.

Alkylating agents are classified according to their nucleophilic or electrophilic character.

Nucleophilic alkylating agents

Nucleophilic alkylating agents deliver the equivalent of an alkyl anion (carbanion). Examples include the use of organometallic compounds such as Grignard (organomagnesium), organolithium, organocopper, and organosodium reagents. These compounds typically can add to an electron-deficient carbon atom such as at a carbonyl group. Nucleophilic alkylating agents can also displace halide substituents on a carbon atom. In the presence of catalysts, they also alkylate alkyl and aryl halides, as exemplified by Suzuki couplings.

Electrophilic alkylating agents

Electrophilic alkylating agents deliver the equivalent of an alkyl cation. Examples include the use of alkyl halides with a Lewis acid catalyst to alkylate aromatic substrates in Friedel-Crafts reactions. Alkyl halides can also react directly with amines to form C-N bonds; the same holds true for other nucleophiles such as alcohols, carboxylic acids, thiols, etc. Trimethyloxonium tetrafluoroborate and triethyloxonium tetrafluoroborate are particularly strong electrophiles due to their overt positive charge and an inert leaving group (dimethyl or diethyl ether).

Electrophilic, soluble alkylating agents are often very toxic, due to their ability to alkylate DNA. They should be handled with proper PPE. This mechanism of toxicity is also responsible for the ability of some alkylating agents to perform as anti-cancer drugs in the form of alkylating antineoplastic agents, and also as chemical weapons such as mustard gas. Alkylated DNA either does not coil or uncoil properly, or cannot be processed by information-decoding enzymes. This results in cytotoxicity with the effects of inhibition the growth of the cell, initiation of programmed cell death or apoptosis. However, mutations are also triggered, including carcinogenic mutations, explaining the higher incidence of cancer after exposure.

Alcohols and phenols can be alkylated to give alkyl ethers:

R-OH + R'-X → R-O-R' + H-X

The produced acid HX is removed with a base, or, alternatively, the alcohol is deprotonated first to give an alkoxide or phenoxide. For example, dimethyl sulfate alkylates the sodium salt of phenol to give anisole, the methyl ether of phenol. The dimethyl sulfate is dealkylated to sodium methylsulfate.^[3]

Ph-O⁻ Na⁺ + Me₂SO₄ → Ph-O-Me + Na⁺ MeSO₄⁻

On the contrary, the alkylation of amines introduces the problem that the alkylation of an amine makes it more nucleophilic. Thus, when an electrophilic alkylating agent is introduced to a primary amine, it will preferentially alkylate all the way to a quaternary ammonium cation.

R-NH₂ → R-NH-R' → R-N(R')₂ → R-N(R')₃⁺ (alkylating agent omitted for clarity)

If the quaternary ammonium is not the desired product, more circuitous routes such as reductive amination are necessary.

Carbene alkylating agents

Carbenes are extremely reactive and are known to attack even unactivated C-H bonds. Carbenes can be generated by elimination of a diazo group. Unlike electrophilic or nucleophilic alkylating agents, carbenes are neutral, and they insert into bonds rather than discard leaving groups. A metal can form a carbene equivalent called a transition metal carbene complex.

In biology

Methylation is the most common type of alkylation, being associated with the transfer of a methyl group. Methylation is distinct from alkylation in that it is specifically the transfer of one carbon, whereas alkylation can refer to the transfer of long chain carbon groups. Methylation in nature is typically effected by vitamin B12-derived enzymes, where the methyl group is carried by cobalt. In methanogenesis, coenzyme M is methylated by tetrahydromethanopterin.

Electrophilic compounds may alkylate different nucleophiles in the body. The toxicity, carcinogenity, and paradoxically, cancer cell-killing abilities of different DNA alkylating agents are an example.

Oil refining

Alkylation of alkenes (shown here is propene) by isobutane is a major process in refineries. It is catalysed by strong acids such as HF and sulfuric acid.

In a standard oil refinery process, isobutane is alkylated with low-molecular-weight alkenes (primarily a mixture of propene and butene) in the presence of a Bronsted acid catalyst, either sulfuric acid or hydrofluoric acid.^[4] In an oil refinery it is referred to as a sulfuric acid alkylation unit (SAAU) or a hydrofluoric alkylation unit, (HFAU). Refinery workers may simply refer to it as the alky or alky unit. The catalyst protonates the alkenes (propene, butene) to produce reactive carbocations, which alkylate isobutane. The reaction is carried out at mild temperatures (0 and 30 °C) in a two-phase reaction. Because the reaction is exothermic, cooling is needed: SAAU plants require lower temperatures so the cooling medium needs to be chilled, for HFAU normal refinery cooling water will suffice. It is important to keep a high ratio of isobutane to alkene at the point of reaction to prevent side reactions which produces a lower octane product, so the plants have a high recycle of isobutane back to feed. The phases separate spontaneously, so the acid phase is vigorously mixed with the hydrocarbon phase to create sufficient contact surface.

The product is called alkylate and is composed of a mixture of high-octane, branched-chain paraffinic hydrocarbons (mostly isoheptane and isooctane). Alkylate is a premium gasoline blending stock because it has exceptional antiknock properties and is clean burning. Alkylate is also a key component of avgas. The octane number of the alkylate depends mainly upon the kind of alkenes used and upon operating conditions. For example, isooctane results from combining butylene with isobutane and has an octane rating of 100 by definition. There are other products in the alkylate, so the octane rating will vary accordingly.

Since crude oil generally contains only 10 to 40 percent of hydrocarbon constituents in the gasoline range, refineries use a fluid catalytic cracking process to convert high molecular weight hydrocarbons into smaller and more volatile compounds, which are then converted into liquid gasoline-size hydrocarbons. Alkylation processes transform low molecular-weight alkenes and iso-paraffin molecules into larger iso-paraffins with a high octane number.

Combining cracking, polymerization, and alkylation can result in a gasoline yield representing 70 percent of the starting crude oil. More advanced processes, such as cyclicization of paraffins and dehydrogenation of naphthenes forming aromatic hydrocarbons in a catalytic reformer, have also been developed to increase the octane rating of gasoline. Modern refinery operation can be shifted to produce almost any fuel type with specified performance criteria from a single crude feedstock.

Refineries examine whether it makes sense economically to install alkylation units. Alkylation units are complex, with substantial economy of scale. In addition to a suitable quantity of feedstock, the price spread between the value of alkylate product and alternate feedstock disposition value must be large enough to justify the installation. Alternative outlets for refinery alklylation feedstocks include sales as LPG, blending of C₄ streams directly into gasoline and feedstocks for chemical plants. Local market conditions vary widely between plants. Variation in the RVP specification for gasoline between countries and between seasons dramatically impacts the amount of butane streams that can be blended directly into gasoline. The transportation of specific types of LPG streams can be expensive so local disparities in economic conditions are often not fully mitigated by cross market movements of alkylation feedstocks.

The availability of a suitable catalyst is also an important factor in deciding whether to build an alkylation plant. If sulfuric acid is used, significant volumes are needed. Access to a suitable plant is required for the supply of fresh acid and the disposition of spent acid. If a sulfuric acid plant must be constructed specifically to support an alkylation unit, such construction will have a significant impact on both the initial requirements for capital and ongoing costs of operation. Alternatively it is possible to install a WSA Process unit to regenerate the spent acid. No drying of the gas takes place. This means that there will be no loss of acid, no acidic waste material and no heat is lost in process gas reheating. The selective condensation in the WSA condenser ensures that the regenerated fresh acid will be 98% w/w even with the humid process gas. It is possible to combine spent acid regeneration with disposal of hydrogen sulfide by using the hydrogen sulfide as internal fuel in the refinery or elsewhere.^[5]

The second main catalyst option is hydrofluoric acid. In typical alkylation plants, rates of consumption for acid are much lower than for sulfuric acid. These plants also produce alkylate with better octane rating than do sulfuric plants. However, due to its hazardous nature, HF acid is produced at very few locations and transportation must be managed rigorously.

References

^ March Jerry; (1985). Advanced Organic Chemistry reactions, mechanisms and structure (3rd ed.). New York: John Wiley & Sons, inc. ISBN 0-471-85472-7
^ Stefanidakis, G.; Gwyn, J.E. (1993). "Alkylation". In John J. McKetta. Chemical Processing Handbook. CRC Press. pp. 80–138. ISBN 0-8247-8701-3.
^ G. S. Hiers and F. D. Hager (1941). "Anisole". Org. Synth. ; Coll. Vol. 1, p. 58
^ Michael Röper, Eugen Gehrer, Thomas Narbeshuber, Wolfgang Siegel "Acylation and Alkylation" in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim, 2000. doi:10.1002/14356007.a01_185
^ Sulphur recovery; (2007). The Process Principles, details advances in sulphur recovery by the WSA process. Denmark: Jens Kristen Laursen, Haldor Topsøe A/S. Reprinted from Hydrocarbonengineering August 2007

External links

Macrogalleria page on polycarbonate production
Alkylating agents at the US National Library of Medicine Medical Subject Headings (MeSH)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 炎症性疾患におけるシクロホスファミドおよびクロラムブシルの全身毒性 general toxicity of cyclophosphamide and chlorambucil in inflammatory diseases
2. 症候性または進行した慢性リンパ性白血病に対する初期治療の選択 selection of initial therapy for symptomatic or advanced chronic lymphocytic leukemia
3. 小児におけるステロイド抵抗性特発性ネフローゼ症候群 steroid resistant idiopathic nephrotic syndrome in children
4. 壊疽性膿皮症：治療および予後 pyoderma gangrenosum treatment and prognosis
5. ブスルファン誘発性肺損傷 busulfan induced pulmonary injury

English Journal

The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.

Podhorecka M1, Klimek P, Chocholska S, Szymczyk A, Macheta A, Kowal M, Dmoszynska A, Hus M.
European journal of clinical pharmacology.Eur J Clin Pharmacol.2015 Sep;71(9):1121-7. doi: 10.1007/s00228-015-1893-0. Epub 2015 Jul 5.
PURPOSE: The problem of drug sensitivity and predicting the outcome of chemotherapy seems to be of great importance in hemato-oncological disorders. There are some factors that can help to predict effects of chemotherapy in chronic lymphocytic leukemia (CLL), such as presence of del17p, del11q, or T
PMID 26141594

O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma.

Chen SH1,2,3, Kuo CC1,4, Li CF2,5,6, Cheung CH7,8, Tsou TC9, Chiang HC9, Yang YN4, Chang SL10, Lin LC11,12, Pan HY3, Chang KY2,13, Chang JY1,2,7,8,13,14.
International journal of cancer. Journal international du cancer.Int J Cancer.2015 Sep;137(6):1291-305. doi: 10.1002/ijc.29486. Epub 2015 Mar 6.
Cisplatin (CDDP) is an important anti-cancer drug commonly used in various human cancers, including nasopharyngeal carcinoma (NPC). How to overcome the drug resistance of CDDP provides opportunities to improve clinical outcomes of NPC. O(6) -methylguanine-DNA methyltransferase (MGMT) has been well-c
PMID 25693518

ETD Outperforms CID and HCD in the Analysis of the Ubiquitylated Proteome.

Porras-Yakushi TR1, Sweredoski MJ, Hess S.
Journal of the American Society for Mass Spectrometry.J Am Soc Mass Spectrom.2015 Sep;26(9):1580-7. doi: 10.1007/s13361-015-1168-0. Epub 2015 May 21.
Comprehensive analysis of the ubiquitylome is a prerequisite to fully understand the regulatory role of ubiquitylation. However, the impact of key mass spectrometry parameters on ubiquitylome analyses has not been fully explored. In this study, we show that using electron transfer dissociation (ETD)
PMID 25994767

Japanese Journal

非ホジキンリンパ腫の治療後に急性巨核芽球性白血病として発症した治療関連急性骨髄性白血病

兒玉聖子,浅野千尋,増田道彦
東京女子医科大学雑誌 83(E2), E604-E607, 2013-03-31
症例は40歳男性。37歳時にanaplastic largecell lymphoma を発症し、拡張型心筋症の合併があることから放射線療法を行った。しかし照射中に表在リンパ節の増大を認めたため、M-COP 療法(cyclophosphamide, vincristine, mitoxantrone, prednisolone)に治療を変更し 8 コース施行した。化学療法終了後1ヶ月で再発し、IC …
NAID 110009575072

Chemotherapy for glioma and primary central nervous system lymphoma

永根基雄
杏林医学会雑誌 43(4), 151-168, 2013
… Temozolomide is an oral alkylating agent with the excellent BBB penetration property, and has been shown significant efficacy in the treatment of glioblastoma, the most malignant glioma. …
NAID 130003364536

Investigating Mechanisms for Non-linear Genotoxic Responses, and Analysing Their Effects in Binary Combination

Johnson George E.,Zair Zoulikha M.,Bodger Owen G. [他],LEWIS Paul D.,REES Ben J.,VERMA Jatin R.,THOMAS Adam D.,DOAK Shareen H.,JENKINS Gareth J. S.
Genes and environment : the official journal of the Japanese Environmental Mutagen Society 34(4), 179-185, 2012-11-20
NAID 10031125867

Related Pictures

★リンクテーブル★

リンク元	「100Cases 34」「alkylate」「alkylation」「アルキル化」
拡張検索	「alkylating agent」「alkylating drug」「alkylating antineoplastic agent」

「100Cases 34」

　　[★]

☆case34　てんかん発作

■症例

23歳　アフリカ-カリブ系　女性　銀行の店員

主訴：てんかん発作

現病歴：強直間代発作を2回起こしたところを母親が目撃していた。娘の行動は次第におかしくなり、また娘は自分のことを話している声が聞こえていた(幻聴)。最近、頭痛を訴えていた。体重が減少し、脱毛があった。盗汗と主に足と手の小関節に及ぶflitting 関節痛を訴えていた。服用薬なし。タバコ1日5-10本、アルコール10 unit/week(缶ビール(350ml)6本弱)

既往歴：特記なし(medical or psychiatric history)

家族歴：

生活歴：

・身体診断

意識：眠そうだが痛みに反応。頚部硬直：なし。頭髪：薄く斑状。体温38.5℃。リンパ節：たくさんの部位で触知。

心拍：104/分、整。血圧：164/102 mmHg。心血管系、呼吸器系、腹部：異常なし。

神経所見：focal anormalityなし(局所性異常)。乳頭浮腫：認めず。

・検査

(血液生化学)

上昇：erythrocyte sedimentation rate、urea、creatinine

低下：hemoglobin、white cell count、platelet

正常：mean corpuscular volume、sodium、potassium、glucose

(腰椎穿刺)

上昇：leukocytes、CSF protein

正常：CSF glucose

(尿検査)

蛋白：＋＋＋。血尿：＋＋＋。赤血球：＋＋。赤血球円柱：あり。

(その他)

胸部X線：異常なし。ECG：洞性頻脈。頭部 CT：正常。CSF グラム染色：陰性(光顕レベルで細菌なし)

■glossary

fall out　(毛髪などが)抜ける

night sweat 盗汗、寝汗

tonic-clonic generalized seizure 全般性強直間代発作

flit　vi (鳥・蝶など)すいすい/ひらひら飛ぶ、飛び回る、飛翔する。(人が)軽やかに通る、行き交う。(時が)(飛ぶように)すぎる。(幻想など)去来する、よぎる、(表情が)かすめる

drowsy　adj. 眠い。眠そうな。眠気を誘う。ものうい。眠ったような

stiffness　n. 堅いこと、堅ぐるしさ、がんこさ

delirium tremens 振戦譫妄

hypertensive encephalopathy 高血圧性脳症

alopecia　脱毛症

African-Caribbean アフリカ-カリブ系

fit n.　(病気の)発作。引きつけ、痙攣。(感情の)激発、一時的興奮、気まぐれ

chorea n. 舞踏病

recreational drug 耽溺性があり乱用される脱法薬物

urgent adj. (物・事が)急を要する、緊急の、背拍質(pressing)。(～を)緊急に必要とする(in)。(S is ～ (with O1) for [in] O2)(人が)(O1(人)に)O2(物・事)をしつこく求める。(人に/～するように)催促する(for/to do)。(要求などが)執拗な。

□てんかん発作

・新規発生したてんかん発作の原因(ICU.805-806)

・薬物中毒(テオフィリンなど)

・薬物からの離脱(アルコールなど)

・感染症(髄膜炎、膿瘍など)

・頭部外傷

・虚血障害(虚血あるいはびまん性)

・占拠性病変(腫瘍あるいは血腫)

・代謝性障害(肝性脳症、尿毒症性脳症、敗血症、低血糖、低ナトリウム血症、低カルシウム血症など)

・合併症(ICU.805-806)